[Federal Register Volume 67, Number 96 (Friday, May 17, 2002)]
[Notices]
[Pages 35123-35124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12446]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the

[[Page 35124]]

provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel, HIV/Drug Interactions.
    Date: June 4, 2002.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 
20814.
    Contact Person: Dale Birkle, PhD, Scientific Review 
Administrator, NIH/NCCAM, 6707 Democracy Blvd., Democracy Two 
Building, Suite 401, Bethesda, MD 20892, (301) 451-6570, 
[email protected].

    Dated: May 13, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-12446 Filed 5-16-02; 8:45 am]
BILLING CODE 4140-01-M